PRO-XTEN Trademark

Trademark Overview


On Wednesday, October 18, 2023, a trademark application was filed for PRO-XTEN with the United States Patent and Trademark Office. The USPTO has given the PRO-XTEN trademark a serial number of 98228513. The federal status of this trademark filing is REGISTERED as of Tuesday, February 18, 2025. This trademark is owned by AMUNIX PHARMACEUTICALS, INC.. The PRO-XTEN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific and technological services, namely, chemical, biological, medical, pharmaceutical and scientific research and development of vaccines and medicines; Scientific research in the nature of conducting of clinical trials for others; Scientific information services by providing scientific data in the field of oncology and immunology diseases.
pro-xten

General Information


Serial Number98228513
Word MarkPRO-XTEN
Filing DateWednesday, October 18, 2023
Status700 - REGISTERED
Status DateTuesday, February 18, 2025
Registration Number7692425
Registration DateTuesday, February 18, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 31, 2024

Trademark Statements


Goods and ServicesScientific and technological services, namely, chemical, biological, medical, pharmaceutical and scientific research and development of vaccines and medicines; Scientific research in the nature of conducting of clinical trials for others; Scientific information services by providing scientific data in the field of oncology and immunology diseases.

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 24, 2023
Primary Code042
First Use Anywhere DateFriday, July 31, 2020
First Use In Commerce DateFriday, July 31, 2020

Trademark Owner History


Party NameAMUNIX PHARMACEUTICALS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameAMUNIX PHARMACEUTICALS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameAMUNIX PHARMACEUTICALS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Saturday, October 21, 2023NEW APPLICATION ENTERED
Tuesday, June 4, 2024ASSIGNED TO EXAMINER
Wednesday, June 5, 2024NON-FINAL ACTION E-MAILED
Wednesday, June 5, 2024NON-FINAL ACTION WRITTEN
Wednesday, June 5, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 3, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 3, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 3, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 4, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 25, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 31, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 31, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 18, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, February 18, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 24, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 5, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, September 5, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED